Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Chemotherapy Followed by Ultrahypofractionated Radiotherapy for Muscle-Invasive Bladder Cancer in Older Adults
NCT07914101Phase 3Not yet recruiting
- Sponsor
- Assiut University
- Start
- Dec 2026
- Primary completion
- Aug 2027
01
Overview
A Phase 3 trial of gemcitabine, Cisplatin micelle injection (HA132), carboplatin in bladder cancer, sponsored by Assiut University. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
gemcitabineCisplatin micelle injection (HA132)carboplatin
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT07914101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07914101.